Skip to content

Follow your curiosity.

Try “brain”, “genomics”, or another subject you follow.

Digital Health · The big question

AI spots early dementia risk in everyday speech pauses

Your “um” and pauses could reveal early dementia risk

Editorial illustration for Your “um” and pauses could reveal early dementia risk
Editorial illustration

Summary

We all stumble over our words occasionally, filling the gaps with a brief pause or a filler word. Researchers have found that these everyday speech patterns are actually closely tied to our executive function, which is the brain's command center for managing tasks like memory, focus, and planning.

To explore this connection, scientists used artificial intelligence to analyze natural, everyday conversations. They discovered that AI can evaluate these speaking patterns to predict a patient's cognitive performance, offering a unique glimpse into how well the brain is functioning. However, it is important to note that this is still early-stage, proof-of-concept research. The current findings do not yet provide specific quantitative data, such as exact predictive accuracy or the total sample size of patients tested, meaning the technology needs more validation before it becomes a standard medical tool.

Why it matters.

Speech-based analysis tools possess the exciting potential to detect early signs of dementia long before traditional clinical testing does. Currently, standard medical evaluations can be extensive and may only identify cognitive decline after the disease has already progressed. A simple software tool that listens to natural conversation could completely change this timeline.

For patients, catching dementia earlier would provide a vital head start on managing their condition, accessing care, and participating in clinical trials. For the medical industry, developing these AI tools could eventually offer a highly accessible, non-invasive screening method that monitors brain health seamlessly through everyday interactions.

From the source

The story in numbers.

Sample size
Not provided
Predictive accuracy rate
Not provided
Keep the context

Follow the evidence.

This AI-assisted summary is a starting point. Read the original reporting for its methods, scope, and limitations.

Your next discovery.

Keep exploring ↗
Digital Health

Upgraded medical AI can now request and analyze diverse diagnostic data.

Imagine chatting with a computer program that not only understands your symptoms but can also act like a medical detective. Researchers have developed a specialized artificial intelligence called the Articulate Medical Intelligence Explorer, or AMIE. This system is a large language model, which is a type of AI trained on vast amounts of text to understand and generate human language. Unlike general conversational programs, AMIE is custom-built specifically to hold diagnostic conversations with patients. Recent upgrades have given AMIE a powerful new set of skills. The AI can now handle multimodal medical data, meaning it can process different kinds of information at the same time. Instead of just passively receiving a list of symptoms, the upgraded system can actively ask for specific medical data, interpret those results, and use that combined information to logically think through a potential diagnosis.

Nature Medicine1 min read
Digital Health

New AI Tool Uses Retinal Scans to Detect Multiple Diseases

Researchers have developed a new artificial intelligence system designed to detect multiple diseases just by analyzing images of the eye. Known as Reti-Pioneer, this computer program examines scans of the retina, the light-sensitive tissue at the back of the eye. By reviewing these pictures, the AI can check for signs of several different health conditions all at once. To build this tool, the research team trained the AI using a massive collection of eye images gathered from various healthcare centers, ranging from local community clinics to large, specialized hospitals. This broad mix of data helps ensure the program works well for different types of patients. The creators then tested the system using outside data, confirming that it performs reliably beyond the original images it was trained on. The system has already been put to the test in real healthcare settings. Through an initial pilot study and a silent trial, where the AI ran in the background without affecting patient care, researchers showed that the tool is fast and practical for doctors to use. However, the study does not yet specify exactly which diseases the AI targets, the exact number of patients tested, or the precise accuracy rates of the diagnoses.

Nature Medicine1 min read
Digital Health

Supreme Court Preserves Telehealth Access to Mifepristone for Now

The Supreme Court has decided that mifepristone, a key medication used in medical abortions, can still be prescribed through telehealth and delivered by mail for the time being. This decision reverses a recent ruling by the 5th Circuit Court of Appeals, which had attempted to temporarily block doctors from prescribing the medication remotely. The legal dispute centers on safety protocols known as Risk Evaluation and Mitigation Strategies. Originally, these rules required patients to obtain mifepristone in person, but the Food and Drug Administration lifted those specific restrictions in 2021 to allow remote prescribing. The state of Louisiana is currently challenging this change in court, arguing that allowing doctors to prescribe the drug via telehealth directly undermines the state's strict abortion ban. It is important to note that the current Supreme Court decision is only a temporary measure. The broader case will continue to move its way through the justice system, meaning the ultimate legality of telehealth distribution for mifepristone remains highly uncertain.

STAT News1 min read

A little science goes a long way.

Clear, thoughtful biotech briefings. In your inbox three times a week.

Stay curious. Subscribe free ↗
AI spots early dementia risk in everyday speech pauses — Daily Strand